Skip to content
value.today

Medcomtech, S.A.: peers

Change the peers

Medcomtech, S.A. beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.

Medcomtech, S.A., Labiana Health, S.A., Vytrus Biotech, S.A., ADL Bionatur Solutions, Euroespes S.A., EuKedos S.p.A., Icecure Medical Ltd, Lisata Therapeutics, Inc.: the market cap on file is more than 60 days old or a last known value (no market-data feed for their exchanges yet), so their valuation multiples and yields are shown but not ranked.

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

Medcomtech, S.A., Labiana Health, S.A., Vytrus Biotech, S.A., ADL Bionatur Solutions, Euroespes S.A., EuKedos S.p.A., Icecure Medical Ltd, Lisata Therapeutics, Inc. side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureMedcomtech, S.A.base
MED.MC · 🇪🇸 ES
Percentile in Healthcare
Percentile in Spain
Labiana Health, S.A.
LAB.MC · 🇪🇸 ES
Percentile in Healthcare
Percentile in Spain
Vytrus Biotech, S.A.
VYT.MC · 🇪🇸 ES
Percentile in Healthcare
Percentile in Spain
ADL Bionatur Solutions
041.SG · 🇪🇸 ES
Percentile in Healthcare
Percentile in Spain
Euroespes S.A.
EEP.MC · 🇪🇸 ES
Percentile in Healthcare
Percentile in Spain
EuKedos S.p.A.
EUK.MI · 🇮🇹 IT
Percentile in Healthcare
Percentile in Italy
Icecure Medical Ltd
ICCM · 🇮🇱 IL
Percentile in Healthcare
Percentile in Israel
Lisata Therapeutics, Inc.
LSTA · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Group median
Size
Market cap (Better neither way: ranked highest first)$10 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one4th of 8$9 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one7th of 8$14 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one3rd of 8$23 Mlast known, Jul 30, 2023 · Market dataLast known value: no current one2nd of 8$4 Mlast known, Jul 30, 2023 · Market dataLast known value: no current one8th of 8$24 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one1st of 8$10 MAug 1, 2026 · Market data4th of 8$10 MAug 1, 2026 · Market data4th of 8$10 M8 ranked
Revenue (Better neither way: ranked highest first)——————————$60 MFY2025 · ESEF1st of 3$3 MFY2025 · SEC2nd of 3$0 MFY2025 · SEC3rd of 3$3 M3 ranked
Net income (Higher is better)——————————$-1 MFY2025 · ESEF1st of 3$-15 MFY2025 · SEC2nd of 3$-17 MFY2025 · SEC3rd of 3$-15 M3 ranked
Employees (Better neither way: ranked highest first)————————————67December 31, 2025 · Profileonly one with it——67—
Growth
Revenue growth (Higher is better)————————————————————+6.7%FY2025 · ESEF1st of 242nd50th+2.7%FY2025 · SEC2nd of 232nd26th————+4.7%2 ranked
Revenue growth, 3 years a year (Higher is better)————————————————————————+3.1%FY2025 · SEConly one with it37th35th————+3.1%—
Earnings per share growth (Higher is better)————————————————————————-20.0%FY2025 · SEConly one with it21st37th————-20.0%—
Margins and returns
Gross margin (Higher is better)————————————————————21.1%FY2025 · ESEF2nd of 210th30th36.4%FY2025 · SEC1st of 222nd43rd————28.7%2 ranked
Operating margin (Higher is better)————————————————————10.2%FY2025 · ESEF1st of 273rd59th-446.4%FY2025 · SEC2nd of 27th14th————-218.1%2 ranked
Net margin (Higher is better)————————————————————-1.4%FY2025 · ESEF1st of 258th10th-445.6%FY2025 · SEC2nd of 26th11th————-223.5%2 ranked
Free cash flow margin (Higher is better)————————————————————0.8%FY2025 · ESEF1st of 254th16th-432.3%FY2025 · SEC2nd of 27th8th————-215.7%2 ranked
Return on equity (Higher is better)————————————————————-2.6%FY2025 · ESEF1st of 371st14th-188.8%FY2025 · SEC3rd of 312th7th-74.7%FY2025 · SEC2nd of 332nd14th-74.7%3 ranked
Valuation
Price to sales (Better neither way: ranked highest first)————————————————————————3.0×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price58.8×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price——
Price to book (Better neither way: ranked highest first)————————————————————————1.1×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price0.7×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price——
Free cash flow yield (Higher is better)————————————————————————-146.1%price Aug 1, 2026 · Market datanot ranked: old priceold priceold price-159.8%price Aug 1, 2026 · Market datanot ranked: old priceold priceold price——
Financial strength
Debt to equity (Lower is better)————————————————————————0.0×FY2025 · SEConly one with it5th7th————0.0×—
Piotroski F-score (Higher is better)————————————4 of 9FY2025 · SEConly one with it——4.0 of 9—
Scorecard
Scorecard (Higher is better)——————————2 of 5FY2025 · Scorecard1st of 36 of 17FY2025 · Scorecard2nd of 31 of 9FY2025 · Scorecard3rd of 335% passed3 ranked
Growth checks (Higher is better)——————————1 of 2FY2025 · Scorecard1st of 32 of 6FY2025 · Scorecard2nd of 30 of 2FY2025 · Scorecard3rd of 333% passed3 ranked
Profitability checks (Higher is better)——————————1 of 3FY2025 · Scorecard1st of 31 of 5FY2025 · Scorecard2nd of 30 of 3FY2025 · Scorecard3rd of 320% passed3 ranked
Financial health checks (Higher is better)————————————3 of 5FY2025 · Scorecard1st of 21 of 3FY2025 · Scorecard2nd of 247% passed2 ranked
Shareholder returns checks (Higher is better)————————————0 of 1FY2025 · Scorecard1st of 20 of 1FY2025 · Scorecard1st of 20% passed2 ranked
Ownership
Held by institutions (Better neither way: ranked highest first)————————————11.1%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 258.2%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 234.7%2 ranked
Institutions holding (Better neither way: ranked highest first)————————————122026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 2392026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 2262 ranked
Institutional holding, change over the quarter (Better neither way: ranked highest first)——————————————+0.5 pp2026-Q2 against 2026-Q1 · 13Fonly one with it+0.5 pp—

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

† The market cap behind this figure is more than 60 days old (no market-data feed for that exchange yet): it is shown but not ranked or given a percentile.

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Medcomtech, S.A.: How market caps are worked out; Labiana Health, S.A.: How market caps are worked out; Vytrus Biotech, S.A.: How market caps are worked out; ADL Bionatur Solutions: How market caps are worked out; Euroespes S.A.: How market caps are worked out; EuKedos S.p.A.: How market caps are worked out; Icecure Medical Ltd: How market caps are worked out; Lisata Therapeutics, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover.

Where each stands in its sector and country: Operating margin#

The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.

Operating margin: each company's figure and its percentile in its sector and its country
CompanyOperating marginIn its sectorIn its country
Medcomtech, S.A.———
Labiana Health, S.A.———
Vytrus Biotech, S.A.———
ADL Bionatur Solutions———
Euroespes S.A.———
EuKedos S.p.A.10.2%FY2025
73rd percentile in Healthcaremedian -7.7%, 674 companies
59th percentile in Italymedian 8.8%, 101 companies
Icecure Medical Ltd-446.4%FY2025
7th percentile in Healthcaremedian -7.7%, 674 companies
14th percentile in Israelmedian -0.2%, 67 companies
Lisata Therapeutics, Inc.———

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

$0 M$17 M$35 M$52 M$70 M20112013201520172019202120232025EuKedos S.p.A. $60 MIcecure Medical Ltd $3 MLisata Therapeutics, Inc. $0 M

Rank in the group

1st2nd3rd20242025EuKedos S.p.A.: 1st of 3 in 2024EuKedos S.p.A.: 1st of 3 in 2025EuKedos S.p.A.Icecure Medical Ltd: 2nd of 3 in 2024Icecure Medical Ltd: 2nd of 3 in 2025Icecure Medical LtdLisata Therapeutics, Inc.: 3rd of 3 in 2024Lisata Therapeutics, Inc.: 3rd of 3 in 2025Lisata Therapeutics, Inc.
Revenue by fiscal year with each company's rank in the group and the source of each figure
Fiscal yearMedcomtech, S.A.Labiana Health, S.A.Vytrus Biotech, S.A.ADL Bionatur SolutionsEuroespes S.A.EuKedos S.p.A.Icecure Medical LtdLisata Therapeutics, Inc.
2025—————$60 MESEF1st$3 MSEC2nd$0 MSEC3rd
2024—————$56 MESEF1st$3 MSEC2nd$1 MSEC3rd
2023——————$3 MSEC—
2022——————$3 MSEC—
2021——————$4 MSEC—
2020——————$4 MSEC—
2019——————$2 MSEC—
2016———————$35 MSEC
2015———————$22 MSEC
2014———————$18 MSEC
2013———————$15 MSEC
2012———————$14 MSEC

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.

Suggested peers of Medcomtech, S.A.#

Companies of the same industry first, then the same sector, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • Labiana Health, S.A.LAB.MC · 🇪🇸 Spain
    Same sector: Healthcare · Similar size: $9 M market cap against $10 M · Same country: Spain
    Market cap $9 M (last known, Jan 5, 2024)
    69 of 100 (industry or sector 25 + size 29 + country 15)
    In the group
  • Vytrus Biotech, S.A.VYT.MC · 🇪🇸 Spain
    Same sector: Healthcare · Similar size: $14 M market cap against $10 M · Same country: Spain
    Market cap $14 M (last known, Jan 5, 2024)
    68 of 100 (industry or sector 25 + size 28 + country 15)
    In the group
  • ADL Bionatur Solutions041.SG · 🇪🇸 Spain
    Same sector: Healthcare (Biotechnology) · Similar size: $23 M market cap against $10 M · Same country: Spain
    Market cap $23 M (last known, Jul 30, 2023)
    65 of 100 (industry or sector 25 + size 25 + country 15)
    In the group
  • Euroespes S.A.EEP.MC · 🇪🇸 Spain
    Same sector: Healthcare (Diagnostics and Research) · Similar size: $4 M market cap against $10 M · Same country: Spain
    Market cap $4 M (last known, Jul 30, 2023)
    64 of 100 (industry or sector 25 + size 24 + country 15)
    In the group
  • EuKedos S.p.A.EUK.MI · 🇮🇹 Italy
    Same sector: Healthcare (Medical Care Facilities) · Similar size: $24 M market cap against $10 M · Same region: Southern Europe · Ratios of the last two fiscal years on file
    Market cap $24 M (last known, Jan 5, 2024) · revenue $60 M (year to December 2025)
    61 of 100 (industry or sector 25 + size 24 + country 7 + figures on file 5)
    In the group
  • Icecure Medical LtdICCM · 🇮🇱 Israel
    Same sector: Healthcare (Medical Care Facilities) · Similar size: $10 M market cap against $10 M · Ratios of the last two fiscal years on file
    Market cap $10 M (Aug 1, 2026) · revenue $3 M (year to December 2025)
    60 of 100 (industry or sector 25 + size 30 + figures on file 5)
    In the group
  • Lisata Therapeutics, Inc.LSTA · 🇺🇸 USA
    Same sector: Healthcare (Biotechnology) · Similar size: $10 M market cap against $10 M · Ratios of the last two fiscal years on file
    Market cap $10 M (Aug 1, 2026) · revenue $0 M (year to December 2025)
    60 of 100 (industry or sector 25 + size 30 + figures on file 5)
    In the group
  • ADM Tronics Unlimited Inc.ADMT · 🇺🇸 USA
    Same sector: Healthcare (Medical Devices) · Similar size: $10 M market cap against $10 M · Ratios of the last two fiscal years on file
    Market cap $10 M (last known, Jul 30, 2023) · revenue $3 M (year to March 2026)
    60 of 100 (industry or sector 25 + size 30 + figures on file 5)
    + Add
  • Immunovia AB (publ)IMMNOV.ST · 🇸🇪 Sweden
    Same sector: Healthcare (Diagnostics and Research) · Similar size: $10 M market cap against $10 M · Ratios of the last two fiscal years on file
    Market cap $10 M (last known, Jan 5, 2024) · revenue $0 M (year to December 2025)
    60 of 100 (industry or sector 25 + size 30 + figures on file 5)
    + Add
  • American Shared Hospital ServicesAMS · 🇺🇸 USA
    Same sector: Healthcare (Medical Care Facilities) · Similar size: $10 M market cap against $10 M · Ratios of the last two fiscal years on file
    Market cap $10 M (Aug 1, 2026) · revenue $28 M (year to December 2025)
    60 of 100 (industry or sector 25 + size 30 + figures on file 5)
    + Add
  • Tempest Therapeutics, Inc.TPST · 🇺🇸 USA
    Same sector: Healthcare (Biotechnology) · Similar size: $10 M market cap against $10 M · Ratios of the last two fiscal years on file
    Market cap $10 M (Oct 27, 2026)
    60 of 100 (industry or sector 25 + size 30 + figures on file 5)
    + Add
  • Bonk, Inc.BNKK · 🇺🇸 USA
    Same sector: Healthcare (Pharmaceutical) · Similar size: $10 M market cap against $10 M · Ratios of the last two fiscal years on file
    Market cap $10 M (Oct 30, 2026) · revenue $2 M (year to December 2025)
    60 of 100 (industry or sector 25 + size 30 + figures on file 5)
    + Add

Any figure over the years, other peers or a saved group: open this group in the peer workspace.